C2N Diagnostics key facts
- Provider of specialty diagnostic testing services intended to offer novel diagnostics for Alzheimer's disease.
- It has raised $95.0M across 2 recorded rounds; the latest was Early Stage VC ($10.0M) in May 2025.
- Notable investors include Samsung Venture Investment, Washington University in St. Louis, GHR Foundation, Alzheimers Drug Discovery Foundation, Diagnostics Accelerator — 9 tracked in total.
- C2N Diagnostics has filed 3 Form Ds with the SEC since 2024, most recently May 2025 ($10.0M sold to 1 investors).
- Status: Privately Held (backing).
- ·Watch C2N Diagnostics: the Monday email on marks, rounds and moves
C2N Diagnostics funding rounds
2 roundsHow much has C2N Diagnostics raised?
C2N Diagnostics has raised $95 million in total; 2 of its rounds are on record. The largest on record was a $10 million early-stage round in May 2025.
C2N Diagnostics has filed 3 Form Ds with the SEC since 2024, most recently in May 2025 ($10 million sold to 1 investor).
C2N Diagnostics investors
9 investors are on record for C2N Diagnostics, including Samsung Venture Investment, Washington University in St. Louis, GHR Foundation and Alzheimers Drug Discovery Foundation. The early-stage round in May 2025 drew 1 investor.
About C2N Diagnostics
Provider of specialty diagnostic testing services intended to offer novel diagnostics for Alzheimer's disease. The company provides precise, accurate, and sensitive mass spectrometry-based analysis for identifying, quantifying, and monitoring proteins, fragments, and other biomolecules implicated in neurological disorders, enabling doctors to assess and characterize neurocognitive conditions.
- Sector
- Healthcare
- HQ
- Saint Louis, MO, United States
- Founded
- 2007
- Employees
- 98
- Website
- c2n.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
C2N Diagnostics doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.